ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentObfeldenEVIIVE AG
EVIIVE AG Logo
Verified· 3 sources

EVIIVE AG

Summary

About the company

EVIIVE AG develops blood-based liquid biopsy diagnostics to support the selection of immunotherapies in oncology. The company researches and builds extracellular vesicle (EV) biomarker platforms, including IMPASS and IMPACT, to profile cell-type specific EV signals and stratify patients for treatment.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered8
Biomarker Discovery Platform
Next-generation biomarker discovery platform for precise diagnostics in immuno-oncology; analysis of extracellular vesicles, treatment selection, response prediction and longitudinal monitoring.
Blood-based Diagnostics
Blood-based diagnostics from small plasma volumes with high-dimensional analysis of extracellular vesicles for non-invasive, clinically relevant insights into immune and tumor signals.
Immuno-Oncology Tests for Treatment Selection and Response Prediction
Diagnostic tests for early patient selection in immuno-oncology; prediction of therapy response, stratification of patient groups and support for treatment decisions.
Companion Diagnostics
Development of companion diagnostics for oncology immunotherapies; support for clinical decisions, patient selection and translational development.
EV Profiling
Profiling of extracellular vesicles to capture dynamic immune, tumor and metabolic interactions; analysis of EV subpopulations from blood samples.
Press

Media

February 28, 2025Media
Eviive forscht erfolgreich in der Krebsdiagnostik und -behandlung
affolteranzeiger.ch
December 27, 2024Media
CHF 150,000 from Venture Kick to bring precision diagnostics to cancer immunotherapies
startupticker.ch

Knowledge

No knowledge articles yet

Once EVIIVE AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

EVIIVE AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank EVIIVE AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of EVIIVE AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Mühlestrasse 4b
8912 Obfelden

At a glance

Legal form
Corporation
UID
CHE-250.572.156
Founded
2024 · 2 years
Last commercial register change
December 4, 2024
Employees
1 to 10

Similar companies

ST
Stiftung Technopark Zürich
Zurich
SO
SwissDrones Operating AG
Zurich
AH
A. Heim GmbH
Fehraltorf
SC
Stem Cell Bank of Switzerland GmbH
Zurich